Cargando…

Letter to the Editor Regarding “Network Meta-analysis of Food and Drug Administration-approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder”

Detalles Bibliográficos
Autores principales: Cree, Bruce A. C., Greenberg, Benjamin, Cameron, Chris, Weinshenker, Brian G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338188/
https://www.ncbi.nlm.nih.gov/pubmed/35779190
http://dx.doi.org/10.1007/s40120-022-00376-2
_version_ 1784759914219962368
author Cree, Bruce A. C.
Greenberg, Benjamin
Cameron, Chris
Weinshenker, Brian G.
author_facet Cree, Bruce A. C.
Greenberg, Benjamin
Cameron, Chris
Weinshenker, Brian G.
author_sort Cree, Bruce A. C.
collection PubMed
description
format Online
Article
Text
id pubmed-9338188
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-93381882022-07-31 Letter to the Editor Regarding “Network Meta-analysis of Food and Drug Administration-approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder” Cree, Bruce A. C. Greenberg, Benjamin Cameron, Chris Weinshenker, Brian G. Neurol Ther Letter Springer Healthcare 2022-07-02 /pmc/articles/PMC9338188/ /pubmed/35779190 http://dx.doi.org/10.1007/s40120-022-00376-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Letter
Cree, Bruce A. C.
Greenberg, Benjamin
Cameron, Chris
Weinshenker, Brian G.
Letter to the Editor Regarding “Network Meta-analysis of Food and Drug Administration-approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder”
title Letter to the Editor Regarding “Network Meta-analysis of Food and Drug Administration-approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder”
title_full Letter to the Editor Regarding “Network Meta-analysis of Food and Drug Administration-approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder”
title_fullStr Letter to the Editor Regarding “Network Meta-analysis of Food and Drug Administration-approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder”
title_full_unstemmed Letter to the Editor Regarding “Network Meta-analysis of Food and Drug Administration-approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder”
title_short Letter to the Editor Regarding “Network Meta-analysis of Food and Drug Administration-approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder”
title_sort letter to the editor regarding “network meta-analysis of food and drug administration-approved treatment options for adults with aquaporin-4 immunoglobulin g-positive neuromyelitis optica spectrum disorder”
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338188/
https://www.ncbi.nlm.nih.gov/pubmed/35779190
http://dx.doi.org/10.1007/s40120-022-00376-2
work_keys_str_mv AT creebruceac lettertotheeditorregardingnetworkmetaanalysisoffoodanddrugadministrationapprovedtreatmentoptionsforadultswithaquaporin4immunoglobulingpositiveneuromyelitisopticaspectrumdisorder
AT greenbergbenjamin lettertotheeditorregardingnetworkmetaanalysisoffoodanddrugadministrationapprovedtreatmentoptionsforadultswithaquaporin4immunoglobulingpositiveneuromyelitisopticaspectrumdisorder
AT cameronchris lettertotheeditorregardingnetworkmetaanalysisoffoodanddrugadministrationapprovedtreatmentoptionsforadultswithaquaporin4immunoglobulingpositiveneuromyelitisopticaspectrumdisorder
AT weinshenkerbriang lettertotheeditorregardingnetworkmetaanalysisoffoodanddrugadministrationapprovedtreatmentoptionsforadultswithaquaporin4immunoglobulingpositiveneuromyelitisopticaspectrumdisorder